EU Court Blocks Regulator From Releasing Drug Trial Data

Law360, New York (April 30, 2013, 3:11 PM EDT) -- A European Union court has blocked the EU’s top drug regulator from granting third-party access to clinical trial information from InterMune Inc. and AbbVie Inc. drug approval applications, dealing a blow to its open document access policy, the watchdog announced Tuesday.

According to the European Medicines Agency, the EU’s General Court has granted interim rulings barring it from providing clinical study and other documents under two freedom of information requests related to marketing authorization applications for AbbVie’s blockbuster rheumatoid arthritis treatment Humira and InterMune’s treatment for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.